Medicare Enrolled
Dr. Faithlore Gardner, MD
Hematology · Cape Coral, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gardner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gardner?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gardner
Dr. Faithlore Gardner is a hematology specialist in Cape Coral, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gardner performed 186,790 Medicare services across 4,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gardner received a total of $82,272 from 97 pharmaceutical and/or device companies across 1199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gardner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 24% volume in FL
$82,272 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 110181 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗186,790
Medicare services
Top 24% in FL for hematology
4,548
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,377 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 54,570 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 24,000 | $43 | $137 |
| Epoetin alfa injection (Procrit) for anemia | 21,210 | $6 | $23 |
| Daratumumab injection (Darzalex) | 15,840 | $38 | $110 |
| Filgrastim injection (Zarxio) for white blood cells | 15,780 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 11,100 | $18 | $51 |
| Iron sucrose injection (Venofer) | 9,100 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 8,190 | $1 | $5 |
| Injection, romiplostim, 10 micrograms | 3,745 | $73 | $197 |
| Immune globulin infusion (Gammagard) | 3,150 | $36 | $108 |
| Complete blood count (CBC) with differential | 2,982 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,743 | $0 | $3 |
| Blood draw (venipuncture) | 2,671 | $8 | $9 |
| Infliximab infusion (Remicade) | 1,670 | $26 | $124 |
| Injection, fulvestrant, 25 mg | 1,540 | $8 | $132 |
| Office visit, established patient (30-39 min) | 1,410 | $98 | $339 |
| Drug injection, under skin or into muscle | 1,254 | $11 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,070 | $1 | $28 |
| Administration of chemotherapy into vein, 1 hour or less | 548 | $102 | $378 |
| Injection of additional new drug or substance into vein | 502 | $12 | $61 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 393 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 340 | $50 | $189 |
| Anti-nausea injection (ondansetron/Zofran) | 332 | $0 | $9 |
| Office visit, established patient (20-29 min) | 276 | $67 | $239 |
| Injection, zoledronic acid, 1 mg | 269 | $7 | $69 |
| Injection, diphenhydramine hcl, up to 50 mg | 199 | $1 | $3 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 175 | $26 | $89 |
| Infusion into a vein for hydration, each additional hour | 163 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 161 | $22 | $79 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 161 | $17 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 156 | $57 | $206 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 136 | $23 | $84 |
| Infusion, normal saline solution , 1000 cc | 126 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 107 | $16 | $56 |
| Infusion into a vein for hydration, 31-60 minutes | 106 | $25 | $156 |
| Administration of additional new drug or substance into vein, 1 hour or less | 98 | $52 | $178 |
| Automated urinalysis | 86 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 78 | $142 | $474 |
| Injection of drug or substance into vein | 64 | $30 | $156 |
| Prothrombin time test (blood clotting) | 46 | $4 | $15 |
| New patient office visit (45-59 min) | 38 | $129 | $453 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 37 | $1 | $7 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 33 | $3 | $11 |
| Red blood count automated, with additional calculations | 30 | $5 | $20 |
| New patient office visit (30-44 min) | 25 | $92 | $298 |
| Drawing of blood for a medical problem | 23 | $68 | $277 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 22 | $16 | $56 |
| Initial hospital admission, moderate complexity | 12 | $107 | $377 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $30 | $115 |
| Red blood count, automated test | 11 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
32.4% high complexity
63.4% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$82,272
Total received (2018-2024)
Avg $11,753/year across 7 years
Top 6% in FL for hematology
97
Companies
1,199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,040 (58.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,305 (23.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$14,928 (18.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,951
2023
$14,689
2022
$10,166
2021
$17,239
2020
$15,398
2019
$6,196
2018
$12,634
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$19,530
Regeneron Healthcare Solutions, Inc.
$17,929
Janssen Biotech, Inc.
$11,440
Epizyme, Inc.,
$6,529
Janssen Scientific Affairs, LLC
$3,316
SANOFI-AVENTIS U.S. LLC
$2,965
NanoString Technologies, Inc.
$1,914
Seattle Genetics, Inc.
$1,644
E.R. Squibb & Sons, L.L.C.
$1,430
Celgene Corporation
$1,190
PFIZER INC.
$1,177
Novartis Pharmaceuticals Corporation
$1,107
Merck Sharp & Dohme LLC
$1,051
Merck Sharp & Dohme Corporation
$956
Genentech USA, Inc.
$693
AstraZeneca Pharmaceuticals LP
$663
Incyte Corporation
$596
Exelixis Inc.
$549
Lilly USA, LLC
$542
Daiichi Sankyo Inc.
$478
ARRAY BIOPHARMA INC
$411
BeiGene USA, Inc.
$410
Astellas Pharma US Inc
$341
Seagen Inc.
$320
Eisai Inc.
$313
GlaxoSmithKline, LLC.
$296
Amgen Inc.
$278
EISAI INC.
$253
Gilead Sciences, Inc.
$251
EMD Serono, Inc.
$251
Takeda Pharmaceuticals U.S.A., Inc.
$203
Bayer HealthCare Pharmaceuticals Inc.
$173
Bayer Healthcare Pharmaceuticals Inc.
$162
Puma Biotechnology, Inc.
$156
TESARO, Inc.
$147
ABBVIE INC.
$146
SOBI, INC
$143
Clovis Oncology, Inc.
$134
Pharmacyclics LLC, An AbbVie Company
$129
Boehringer Ingelheim Pharmaceuticals, Inc.
$125
Foundation Medicine, Inc.
$107
Agios Pharmaceuticals, Inc.
$106
Alexion Pharmaceuticals, Inc.
$88
Rigel Pharmaceuticals, Inc.
$85
TerSera Therapeutics LLC
$77
JAZZ PHARMACEUTICALS INC.
$67
PharmaEssentia USA Corporation
$66
AbbVie, Inc.
$66
Mirati Therapeutics, Inc.
$66
MorphoSys, US Inc.
$60
Dova Pharmaceuticals
$58
PUMA BIOTECHNOLOGY, INC.
$49
CTI BioPharma Corp.
$48
Sumitomo Pharma America, Inc.
$45
AbbVie Inc.
$42
Myovant Sciences Inc.
$40
Kyowa Kirin, Inc.
$39
ADC Therapeutics America, Inc.
$38
Acrotech Biopharma LLC
$36
Janssen Pharmaceuticals, Inc
$35
Kite Pharma, Inc.
$34
Taiho Oncology, Inc.
$33
Karyopharm Therapeutics Inc.
$31
Dendreon Pharmaceuticals LLC
$28
GE HEALTHCARE
$28
Adaptive Biotechnologies Corporation
$25
Teva Pharmaceuticals USA, Inc.
$25
SERVIER PHARMACEUTICALS LLC
$24
Genmab U.S., Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$24
Sun Pharmaceutical Industries Inc.
$23
Sysmex Inostics Inc
$23
G1 Therapeutics, Inc.
$21
Novo Nordisk Inc
$21
ImmunoGen, Inc.
$20
Aveo Pharmaceuticals, Inc.
$20
Deciphera Pharmaceuticals Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$18
Sobi, Inc
$17
Epizyme, Inc.
$17
Cumberland Pharmaceuticals, Inc.
$17
Lexicon Pharmaceuticals, Inc.
$16
GE HealthCare
$16
Ipsen Biopharmaceuticals, Inc
$16
Medtronic, Inc.
$16
Veracyte, Inc.
$16
Immunocore Limited
$15
Aurobindo Pharma USA, Inc.
$14
Horizon Therapeutics plc
$14
Spectrum Pharmaceuticals Inc.
$13
Acceleron Pharma, Inc.
$13
Fortovia Therapeutics, Inc.
$12
Jazz Pharmaceuticals Inc.
$12
Blueprint Medicines Corporation
$11
Secura Bio, Inc.
$11
SECURA BIO, INC.
$11
Top 3 companies account for 59.4% of total payments
Associated products mentioned in payments ›
6 · ABECMA · ADAKVEO · ADCETRIS · ADVATE · AFINITOR · ALIMTA · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · COPIKTRA · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · Esperoct · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · HYQVIA · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JAYPIRCA · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARQIBO · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SPRYCEL · SUTENT · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAXOTERE · TAZVERIK · TECVAYLI · TEPMETKO · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYKADIA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for hematology in FL.
Equivalent to $44 per 100 Medicare services performed
Geographic Context
Hematologists within 10 mi
13
Per 100K population
1.6
County median income
$73,099
Nearest hospital
CAPE CORAL HOSPITAL
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gardner is a mixed practice specialist, with above-average Medicare volume (top 24% in FL), with speaking/promotional industry engagement in the top 6% of FL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gardner experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gardner performed 54,570 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gardner receive payments from pharmaceutical companies?
Yes. Dr. Gardner received a total of $82,272 from 97 companies across 1,199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gardner's costs compare to other hematologists in Cape Coral?
Dr. Gardner's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gardner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Cape Coral
Browse hematologists in Cape Coral ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology